These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Status of leukotrienes in the pathophysiology of asthma. Necessity for antileukotrienes treatment]. Fal AM, Kopeć A. Pneumonol Alergol Pol; 2010 Jun; 78(1):68-73. PubMed ID: 20162521 [Abstract] [Full Text] [Related]
5. [Novel treatment of bronchial asthma: application of leukotriene receptor antagonists and leukotriene synthesis inhibitors]. Diamant Z, Sterk PJ. Ned Tijdschr Geneeskd; 1998 Jan 10; 142(5):72-8. PubMed ID: 12013053 [Abstract] [Full Text] [Related]
6. [May the Force be with antileukotriene drugs]. Szczeklik A. Pneumonol Alergol Pol; 2010 Jan 10; 78(1):1-2. PubMed ID: 20162512 [No Abstract] [Full Text] [Related]
10. [Leukotrienes and asthma. Clinical and experimental experiences with leukotriene receptor antagonists and leukotriene synthesis inhibitors]. Henriksen AH, Bjermer L. Tidsskr Nor Laegeforen; 1997 Feb 20; 117(5):647-51. PubMed ID: 9102953 [Abstract] [Full Text] [Related]
14. Use of leukotriene antagonists in childhood asthma. Krawiec ME, Wenzel SE. Curr Opin Pediatr; 1999 Dec 20; 11(6):540-7. PubMed ID: 10590913 [Abstract] [Full Text] [Related]
15. Lipid mediator pathways in the lung: leukotrienes as a new target for the treatment of asthma. Dahlén SE. Clin Exp Allergy; 1998 Nov 20; 28 Suppl 5():141-6; discussion 171-3. PubMed ID: 9988460 [Abstract] [Full Text] [Related]